TABLE 3.

GBM and AA Deaths Stratified by ND and RD Along With Various Survival Estimates

Diagnosis, Status	Total	# Failed	Median Survival in Months (95% CI)	1 Year Survival (95% CI)	2 Year Survival (95% CI)	3 Year Survival (95% CI)	5 Year Survival (95% CI)
AA, ND	103	67	22.2 (18.4, 33.1)	76.4% (66.6%, 83.6%)	44.6% (33.9%, 54.7%)	37% (26.5%, 47.5%)	19.4% (10.8%, 29.9%)
AA, RD	96	54	19.5 (16.2, 29.7)	80.4% (70.3%, 87.3%)	42.6% (31.2%, 53.4%)	35.9% (25%, 47%)	28% (17.6%, 39.4%)
GBM, ND	647	534	16 (14.6, 17.1)	63.5% (59.5%, 67.2%)	28.1% (24.4%, 31.9%)	14.2% (11.3%, 17.4%)	3.6% (2.1%, 5.8%)
GBM, RD	335	267	13.1 (11.4, 13.9)	52.7% (47%, 58.1%)	20.7% (16.1%, 25.7%)	12.5% (8.7%, 17%)	5.9% (3.2%, 9.7%)

AA, anaplastic astrocytoma; GBM, glioblastoma; ND, newly diagnosed; RD, recurrent disease.